Orly Mishan

Ms. Mishan has over 25 years of medical products industry experience, including over 10 years at Boston Scientific and 3 years in implantable diagnostics at Senseonics. As part of the founding team of Bain Capital Life Sciences (BCLS), Ms. Mishan joined the board of Kestra Medical after leading BCLS’ investment in Kestra in 2017. She has held various executive roles at Pfizer, Biogen, and most recently as the Chief Business Officer and then Advisor to Cerevel Therapeutics. Ms. Mishan began her career at McKinsey & Company, serving companies in the life sciences and finance sectors. Ms. Mishan received her B.A. from Columbia College, Columbia University.